Close Menu

NEW YORK — Australian diagnostics firm SpeeDx said on Tuesday that it has raised $15 million in new Series B funding.

The investment was made by Northpond Ventures, which last year invested $20 million in SpeeDx. 

The firm will use the additional funds to support its product and services pipeline, SpeeDx CFO Bhavin Raval said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.